Serum metabolic profiling in inflammatory bowel disease

Area of Science:

• Biochemistry
• Metabolomics
• Medical Diagnostics

Background:

• Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic gastrointestinal inflammatory conditions with unclear pathogenesis.
• Serum (1)H nuclear magnetic resonance (NMR) spectroscopy provides comprehensive metabolic profiles reflecting systemic metabolism, which can be altered in disease states.

Purpose of the Study:

• To investigate Crohn's disease (CD) and ulcerative colitis (UC) patients using (1)H NMR-based serum metabolic profiling.
• To gain insights into disordered metabolism in inflammatory bowel diseases (IBD) and their underlying disease mechanisms.

Main Methods:

• Acquired serum metabolic profiles from 67 individuals: 24 CD patients, 20 UC patients, and 23 healthy controls.
• Employed multivariate pattern-recognition techniques, including principal components analysis (PCA) and orthogonal signal correction partial least squares discriminant analysis (OSC-PLS-DA), to analyze cohort differences.

Main Results:

• OSC-PLS-DA successfully differentiated CD and UC cohorts with significant predictive accuracy, indicating altered lipid and choline metabolism.
• Metabolic profiles of both CD and UC cohorts, and the combined IBD cohort, significantly differed from controls.
• Key metabolites identified by OSC-PLS-DA included lipoproteins (notably HDL cholesterol), choline, N-acetylglycoprotein, and amino acids.

Conclusions:

• (1)H NMR-based metabolic profiling identified distinct serum metabolic phenotypes differentiating CD and UC patients.
• Significant metabolic differences were observed between inflammatory bowel disease (IBD) patients and healthy controls.